MDIT - Medite Cancer Diagnostics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue6,8139,2389,88710,983
Cost of Revenue6,6515,6086,0847,164
Gross Profit1623,6303,8033,819
Operating Expenses
Research Development1,1881,4771,2781,243
Selling General and Administrative5,1613,6002,9472,800
Non Recurring----
Others----
Total Operating Expenses13,29310,89910,48611,377
Operating Income or Loss-6,480-1,661-599-394
Income from Continuing Operations
Total Other Income/Expenses Net-818-634-182-201
Earnings Before Interest and Taxes-6,480-1,661-599-394
Interest Expense-849-694-204-276
Income Before Tax-7,298-2,295-781-595
Income Tax Expense-487-13278104
Minority Interest----
Net Income From Continuing Ops-6,811-2,163-859-699
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,811-2,163-859-699
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,902-2,254-937-808